I agree this company looks great and think it is a bargain. Next catalyst should be the full recruitment of the phase 3 trial for US Bronchitol. Will also be interesting to see quarterly cash flow to see how much expenditure has dropped for their sales operations and if revenue is increasing.
Ann: Annual Report to shareholders, page-3
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.1¢ |
Change
-0.002(6.06%) |
Mkt cap ! $40.00M | |||
| Open | High | Low | Value | Volume |
| 3.3¢ | 3.3¢ | 3.1¢ | $10.37K | 325.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 354657 | 3.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.3¢ | 210596 | 1 |
View Market Depth
| Last trade - 15.43pm 18/09/2024 (20 minute delay) ? |
| SNT (ASX) Chart |